• 1
    Steinman R. M., Hawiger D. and Nussenzweig M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685711.
  • 2
    Sharpe A. H., Wherry E. J., Ahmed R. and Freeman G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007. 8: 239245.
  • 3
    Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235238.
  • 4
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 5
    MacDonald A. S. and Maizels R. M., Alarming dendritic cells for Th2 induction. J. Exp. Med. 2008. 205: 1317.
  • 6
    Constant S. L., Brogdon J. L., Piggott D. A., Herrick C. A., Visintin I., Ruddle N. H. and Bottomly K., Resident lung antigen-presenting cells have the capacity to promote Th2 T-cell differentiation in situ. J. Clin. Invest. 2002. 110: 14411448.
  • 7
    Iwasaki A. and Kelsall B. L., Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 1999. 190: 229239.
  • 8
    Wegmann T. G., Lin H., Guilbert L. and Mosmann T. R., Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 1993. 14: 353356.
  • 9
    Lin H., Mosmann T. R., Guilbert L., Tuntipopipat S. and Wegmann T. G., Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 1993. 151: 45624573.
  • 10
    Saito S., Nakashima A., Shima T. and Ito M., Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010. 63: 601610.
  • 11
    Watanabe S. and Chou J. Y., Isolation and characterization of complementary DNAs encoding human pregnancy-specific beta 1-glycoprotein. J. Biol. Chem. 1988. 263: 20492054.
  • 12
    Masson G. M., Anthony F. and Wilson M. S., Value of Schwangerschaftsprotein 1 (SP1) and pregnancy-associated plasma protein-A (PAPP-A) in the clinical management of threatened abortion. Br. J. Obstet. Gynaecol. 1983. 90: 146149.
  • 13
    Grudzinskas J., Gordon Y., Menabawey M., Lee J., Wadsworth J. and Chard T., Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein. Am. J. Obstet. Gynecol. 1983. 147: 1012.
  • 14
    Salem H., Lee J., Seppala M., Vaara L., Aula P., Al-Ani A. and Chard T., Measurement of placental protein 5, placental lactogen and pregnancy-specific beta 1 glycoprotein in mid-trimester as a predictor of outcome of pregnancy. Br. J. Obstet. Gynaecol. 1981. 88: 371374.
  • 15
    Bohn H. and Weinmann E., Immunological disruption of implantation in monkeys with antibodies to human pregnancy specific beta 1-glycoprotein (SP1) (author's transl). Arch. Gynakol. 1974. 217: 209218.
  • 16
    Motran C. C., Diaz F. L., Gruppi A., Slavin D., Chatton B. and Bocco J. L., Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T-cell proliferation. J. Leukoc. Biol. 2002. 72: 512521.
  • 17
    Motran C. C., Diaz F. L., Montes C. L., Bocco J. L. and Gruppi A., In vivo expression of recombinant pregnancy-specific glycoprotein 1a induces alternative activation of monocytes and enhances Th2-type immune response. Eur. J. Immunol. 2003. 33: 30073016.
  • 18
    Snyder S. K., Wessner D. H., Wessells J. L., Waterhouse R. M., Wahl L. M., Zimmermann W. and Dveksler G. S., Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am. J. Reprod. Immunol. 2001. 45: 205216.
  • 19
    Wessells J., Wessner D., Parsells R., White K., Finkenzeller D., Zimmermann W. and Dveksler G., Pregnancy specific glycoprotein 18 induces IL-10 expression in murine macrophages. Eur. J. Immunol. 2000. 30: 18301840.
  • 20
    Geginat G., Lalic M., Kretschmar M., Goebel W., Hof H., Palm D. and Bubert A., Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J. Immunol. 1998. 160: 60466055.
  • 21
    Sacks G., Sargent I. and Redman C., An innate view of human pregnancy. Immunol. Today 1999. 20: 114118.
  • 22
    Ha C. T., Waterhouse R., Wessells J., Wu J. A. and Dveksler G. S., Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE2, and TGF-beta1. J. Leukoc. Biol. 2005. 77: 948957.
  • 23
    Barrientos G., Tirado-Gonzalez I., Klapp B. F., Karimi K., Arck P. C., Garcia M. G. and Blois S. M., The impact of dendritic cells on angiogenic responses at the fetal-maternal interface. J. Reprod. Immunol. 2009. 83: 8594.
  • 24
    Conejo-Garcia J. R., Benencia F., Courreges M. C., Kang E., Mohamed-Hadley A., Buckanovich R. J., Holtz D. O. et al., Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 2004. 10: 950958.
  • 25
    Ha C. T., Wu J. A., Irmak S., Lisboa F. A., Dizon A. M., Warren J. W., Ergun S. et al., Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biol. Reprod. 2010. 83: 2735.
  • 26
    Wu J. A., Johnson B. L., Chen Y., Ha C. T. and Dveksler G. S., Murine pregnancy-specific glycoprotein 23 induces the proangiogenic factors transforming-growth factor beta 1 and vascular endothelial growth factor a in cell types involved in vascular remodeling in pregnancy. Biol. Reprod. 2008. 79: 10541061.
  • 27
    Koga K. and Mor G., Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am. J. Reprod. Immunol. 2010. 63: 587600.
  • 28
    Petroff M. G., Chen L., Phillips T. A., Azzola D., Sedlmayr P. and Hunt J. S., B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 2003. 68: 14961504.
  • 29
    Guleria I., Khosroshahi A., Ansari M. J., Habicht A., Azuma M., Yagita H., Noelle R. J. et al., A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 2005. 202: 231237.
  • 30
    Blois S. M., Alba Soto C. D., Tometten M., Klapp B. F., Margni R. A. and Arck P. C., Lineage, maturity, and phenotype of uterine murine dendritic cells throughout gestation indicate a protective role in maintaining pregnancy. Biol. Reprod. 2004. 70: 10181023.
  • 31
    Rincon M., Anguita J., Nakamura T., Fikrig E. and Flavell R. A., Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+T cells. J. Exp. Med. 1997. 185: 461470.
  • 32
    Dodge I. L., Carr M. W., Cernadas M. and Brenner M. B., IL-6 production by pulmonary dendritic cells impedes Th1 immune responses. J. Immunol. 2003. 170: 44574464.
  • 33
    Francisco L. M., Salinas V. H., Brown K. E., Vanguri V. K., Freeman G. J., Kuchroo V. K. and Sharpe A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009. 206: 30153029.
  • 34
    Huber S., Gagliani N., Esplugues E., O'Connor W., Huber F. J., Francis J., Chaudhry A. et al., Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+T cells in an interleukin-10-dependent manner. Immunity 2011. 34: 554565.
  • 35
    Chaudhry A., Samstein, Robert M., Treuting P., Liang Y., Pils, Marina C., Heinrich J.-M., Jack, Robert S. et al., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011. 34: 566578.
  • 36
    Schreiner B., Bailey S., Shin T., Chen L. and Miller S., PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur. J. Immunol. 2008. 38: 27062717.
  • 37
    Carter L. L., Leach M. W., Azoitei M. L., Cui J., Pelker J. W., Jussif J., Benoit S. et al., PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007. 182: 124134.
  • 38
    McGeachy M. and Cua D., Th17 cell differentiation: the long and winding road. Immunity 2008. 28: 445453.
  • 39
    Frick J. S., Zahir N., Müller M., Kahl F., Bechtold O., Lutz M. B., Kirschning C. J. et al., Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6. Eur. J. Immunol. 2006. 36: 15371547.
  • 40
    Wölfle S. J., Strebovsky J., Bartz H., Sähr A., Arnold C., Kaiser C., Dalpke A. H. et al., PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J. Immunol. 2011. 41: 413424.
  • 41
    Ertelt J. M., Rowe J. H., Johanns T. M., Lai J. C., McLachlan J. B. and Way S. S., Selective priming and expansion of antigen-specific Foxp3-CD4+T cells during Listeria monocytogenes infection. J. Immunol. 2009. 182: 30323038.
  • 42
    Kammerer U., von Wolff M. and Markert U. R., Immunology of human endometrium. Immunobiology 2004. 209: 569574.
  • 43
    Vanaudenaerde B. M., Dupont L. J., Wuyts W. A., Verbeken E. K., Meyts I., Bullens D. M., Dilissen E. et al., The role of interleukin-17 during acute rejection after lung transplantation. Eur. Respir. J. 2006. 27: 779787.
  • 44
    McGeachy M., Bak-Jensen K., Chen Y., Tato C., Blumenschein W., McClanahan T. and Cua D., TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007. 8: 13901397.
  • 45
    Collins M., Tay C. and Erlebacher A., Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Invest. 2009. 119: 20622073.
  • 46
    Pongcharoen S., Niumsup P., Sanguansermsri D., Supalap K. and Butkhamchot P., The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Am. J. Reprod. Immunol. 2006. 55: 291300.
  • 47
    Lutz M. B., Kukutsch N., Ogilvie A. L., Rossner S., Koch F., Romani N. and Schuler G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 7792.
  • 48
    Pope C., Kim S. K., Marzo A., Masopust D., Williams K., Jiang J., Shen H. et al., Organ-specific regulation of the CD8 T-cell response to Listeria monocytogenes infection. J. Immunol. 2001. 166: 34023409.